Pfizer/Upjohn White Paper Provides Review Of Research, Strategies To Address NCDs Globally

Pfizer/Upjohn: Leading the Conversation on Noncommunicable Diseases Worldwide: An Evidence-Based Review of Key Research and Strategies to Develop Sustainable Solutions
This white paper provides a review of research and strategies to address noncommunicable diseases (NCDs), including descriptions of the global NCD burden, causes of NCDs, global and regional trends, interventions to address NCDs, stakeholders involved in managing NCDs, and potential solutions to address NCDs (February 2020).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.